Sagimet Biosciences Inc (SGMT) USD0.0001 A

Sell:$5.10Buy:$5.35Price decreased$0.13 (2.43%)

Prices delayed by at least 15 minutes
Sell:$5.10
Buy:$5.35
Change:Price decreased$0.13 (2.43%)
Prices delayed by at least 15 minutes
Sell:$5.10
Buy:$5.35
Change:Price decreased$0.13 (2.43%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
10 February 2026
David HappelPresident/CEO
Sell
Tax related
12,101$5.36$64,864.99677,621
10 February 2026
Elizabeth RozekGeneral Counsel
Sell
Tax related
2,622$5.36$14,054.44190,959
10 February 2026
Eduardo Bruno MartinsChief Level Officer
Sell
Tax related
3,640$5.36$19,511.13103,296
10 February 2026
Thierry ChaucheCFO
Sell
Tax related
1,312$5.36$7,032.7115,688
20 November 2025
George W KembleExecutive Chairman
Sell
Regular sell transaction (market)
37,688$7.69$289,979.0181,005
21 July 2025
David HappelPresident/CEO
Sell
Tax related
65,478$9.13$598,115.34689,722
21 July 2025
Elizabeth RozekGeneral Counsel
Sell
Tax related
10,780$9.13$98,470.99183,726
21 July 2025
Eduardo Bruno MartinsChief Level Officer
Sell
Tax related
8,277$9.13$75,607.08106,936

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
21 July 2025
David HappelPresident/CEO
Sell
Tax related
65,478$9.13$598,115.34689,722
20 November 2025
George W KembleExecutive Chairman
Sell
Regular sell transaction (market)
37,688$7.69$289,979.0181,005
21 July 2025
Elizabeth RozekGeneral Counsel
Sell
Tax related
10,780$9.13$98,470.99183,726
21 July 2025
Eduardo Bruno MartinsChief Level Officer
Sell
Tax related
8,277$9.13$75,607.08106,936
10 February 2026
David HappelPresident/CEO
Sell
Tax related
12,101$5.36$64,864.99677,621

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.